Influences of Vitamin A on Vaccine Immunogenicity and Efficacy
Vitamin A deficiencies and insufficiencies are widespread in developing countries, and may be gaining prevalence in industrialized nations. To combat vitamin A deficiency (VAD), the World Health Organization (WHO) recommends high-dose vitamin A supplementation (VAS) in children 6–59 months of age in...
Main Authors: | Rhiannon R. Penkert, Hannah M. Rowe, Sherri L. Surman, Robert E. Sealy, Jason Rosch, Julia L. Hurwitz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01576/full |
Similar Items
-
Nuclear Receptors, Ligands and the Mammalian B Cell
by: Bart G. Jones, et al.
Published: (2020-07-01) -
Will Attention by Vaccine Developers to the Host’s Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?
by: Robert E. Sealy, et al.
Published: (2019-02-01) -
Consequences of Vitamin A Deficiency: Immunoglobulin Dysregulation, Squamous Cell Metaplasia, Infectious Disease, and Death
by: Sherri L. Surman, et al.
Published: (2020-08-01) -
Retinol Binding Protein, Sunlight Hours, and the Influenza Virus-Specific Immune Response
by: Nehali Patel, et al.
Published: (2022-09-01) -
Factors influencing influenza and pneumococcal immunization rates of COPD patients in Bolu, Turkey
by: Manolya Ballar, et al.
Published: (2020-03-01)